End-to-End Reliability of Automated Systems for Diagnostic Evidence Extraction: A Prospective Benchmark Study

Why It Matters

Reliable AI extraction can dramatically speed diagnostic meta‑analyses, lowering labor costs and accelerating evidence‑based decision making in healthcare.

Key Takeaways

• MedNuggetizer hit 97.5% correct extraction across 320 runs
• Claude Opus 4.5 achieved highest exact‑match rate at 97.81%
• Both systems surpassed 95% reliability threshold for diagnostic data
• Automated extraction cut time to under 15 minutes vs. 42 minutes manually
• Gemini 3 Pro missed the 95% benchmark, achieving 94.06% correctness

Pulse Analysis

The synthesis of diagnostic test accuracy studies hinges on the flawless extraction of 2 × 2 contingency tables. Even a single mis‑recorded cell can skew pooled sensitivity, specificity, and downstream health‑economic models. Traditionally, trained reviewers spend upwards of 40 minutes per study, a bottleneck that limits the speed of guideline updates and meta‑analyses. Recent advances in large language models (LLMs) promise to automate this labor‑intensive step, yet their performance under strict, non‑interactive conditions has remained unclear. Understanding whether AI can reliably replace human extractors is critical for scaling evidence‑based medicine.

In a prospective benchmark, four AI systems—MedNuggetizer, ChatGPT‑5.2, Claude Opus 4.5, and Gemini 3 Pro—were tasked with extracting data from 16 diagnostic datasets covering Uromonitor and urine cytology. Each model ran 20 locked‑prompt iterations, producing 320 dataset‑run observations per system. MedNuggetizer and Claude Opus 4.5 achieved 97.5% and 97.8% overall correctness, comfortably exceeding the pre‑specified 95% reliability threshold, while ChatGPT‑5.2 and Gemini 3 Pro fell short at 96.3% and 94.1%. Repeatability was high (Gwet’s AC1 0.93–0.96), and execution times dropped to 7–14 minutes, a three‑fold speedup over the 42‑minute human baseline.

The findings signal a turning point for systematic review pipelines. With two models meeting stringent accuracy and safety criteria, organizations can consider integrating AI‑driven extraction to accelerate guideline development, regulatory submissions, and health‑technology assessments. The modest hallucination rate—only one erroneous numeric output from Claude Opus 4.5—highlights the need for vigilant oversight, especially on non‑derivable studies where abstention is essential. As LLMs continue to evolve, future work should explore domain‑specific fine‑tuning, real‑time validation frameworks, and cost‑benefit analyses to ensure that automation enhances, rather than compromises, the credibility of diagnostic evidence synthesis.